ofatumumab FDA Link

an anti-CD20 MAb used as an antineoplastic agent; in phase 1-2 clinical trials

Also Known As:

GSK-1841157; GSKI841157; HUMAX-CD20 2F2; HUMAX-CD20, 2F2; HUMAX-CD20-2F2; arzerra; kesimpta

ofatumumab Products